<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: We analyzed our data on patients undergoing transcatheter <z:hpo ids='HP_0001655'>patent foramen ovale</z:hpo> (<z:mp ids='MP_0004225'>PFO</z:mp>) closure to determine if the maximal potential <z:mp ids='MP_0004225'>PFO</z:mp> diameter (MPPD) by balloon sizing correlates with important clinical characteristics in this population </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: We defined <z:hpo ids='HP_0001297'>stroke</z:hpo> as a focal neurologic deficit lasting &gt;24 h, or focal deficit of shorter duration associated with permanent MRI/CT changes consistent with a focal infarction </plain></SENT>
<SENT sid="2" pm="."><plain>Parameters analyzed included age, gender, anticoagulation, <z:hpo ids='HP_0000822'>hypertension</z:hpo>, smoking, MRI/CT findings and MPPD at catheterization </plain></SENT>
<SENT sid="3" pm="."><plain>We specifically analyzed the type of neurologic event (<z:hpo ids='HP_0001297'>stroke</z:hpo>/<z:hpo ids='HP_0002326'>transient ischemic attack</z:hpo>, <z:hpo ids='HP_0002326'>TIA</z:hpo>), and number of recorded preceding clinical neurologic events </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: In 216 consecutive patients, 167 suffered a <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>MRI/CT changes consistent with one or more embolic events were seen in 156 patients; 49 had a clinical <z:hpo ids='HP_0002326'>TIA</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>There was no significant difference in MPPD between <z:hpo ids='HP_0001297'>stroke</z:hpo> (11.0 +/- 3.6 mm) and <z:hpo ids='HP_0002326'>TIA</z:hpo> groups (10.9 +/- 3.9 mm; 95% confidence interval for difference: -1.33 to 1.00) </plain></SENT>
<SENT sid="7" pm="."><plain>MPPD did not differ between MRI/CT-positive vs. -negative <z:hpo ids='HP_0001297'>strokes</z:hpo>, and had no correlation with the number of identified pre-closure clinical neurologic events </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Continued investigation is needed to determine whether other <z:mp ids='MP_0004225'>PFO</z:mp> characteristics, or other anatomic/physiologic parameters, may be useful to identify patients at high risk for cryptogenic <z:hpo ids='HP_0001297'>stroke</z:hpo>/<z:hpo ids='HP_0002326'>TIA</z:hpo>, even before they have their first neurologic event </plain></SENT>
</text></document>